168 related articles for article (PubMed ID: 35177827)
1. Early vascular toxicity after pediatric allogeneic hematopoietic stem cell transplantation.
Leimi L; Jahnukainen K; Olkinuora H; Meri S; Vettenranta K
Bone Marrow Transplant; 2022 May; 57(5):705-711. PubMed ID: 35177827
[TBL] [Abstract][Full Text] [Related]
2. Interplay of Inflammation and Endothelial Dysfunction in Bone Marrow Transplantation: Focus on Hepatic Veno-Occlusive Disease.
Vion AC; Rautou PE; Durand F; Boulanger CM; Valla DC
Semin Thromb Hemost; 2015 Sep; 41(6):629-43. PubMed ID: 26305238
[TBL] [Abstract][Full Text] [Related]
3. Rare variants in complement system genes associate with endothelial damage after pediatric allogeneic hematopoietic stem cell transplantation.
Leimi L; Koski JR; Kilpivaara O; Vettenranta K; Lokki AI; Meri S
Front Immunol; 2023; 14():1249958. PubMed ID: 37771589
[TBL] [Abstract][Full Text] [Related]
4. Successful Treatment of Veno-occlusive Disease, Transplantation-Associated Thrombotic Microangiopathy, and Acute Graft-vs-Host Disease in a Patient with Relapsed Epstein-Barr Hemophagocytic Lymphohistiocytosis After Haploidentical Hematopoietic Stem Cell Transplantation: A Case Report.
Zhang C; Tan X; Yao H; Liu Y; Gao L; Gao L; Kong PY; Zhang X
Transplant Proc; 2019 Nov; 51(9):3159-3162. PubMed ID: 31711585
[TBL] [Abstract][Full Text] [Related]
5. Endothelial cell function and endothelial-related disorders following haematopoietic cell transplantation.
Hildebrandt GC; Chao N
Br J Haematol; 2020 Aug; 190(4):508-519. PubMed ID: 32319084
[TBL] [Abstract][Full Text] [Related]
6. Endothelial dysfunction and vascular complications after allogeneic hematopoietic cell transplantation: an expert analysis.
Eftychidis I; Sakellari I; Anagnostopoulos A; Gavriilaki E
Expert Rev Hematol; 2021 Sep; 14(9):831-840. PubMed ID: 34388057
[TBL] [Abstract][Full Text] [Related]
7. Thrombosis in stem cell transplantation.
Kansu E
Hematology; 2012 Apr; 17 Suppl 1():S159-62. PubMed ID: 22507809
[TBL] [Abstract][Full Text] [Related]
8. Potential factors for and the prognostic impact of ascites after allogeneic hematopoietic stem cell transplantation.
Kubo H; Imataki O; Fukumoto T; Kawanaka Y; Ishida T; Kubo YH; Kida JI; Uemura M; Fujita H; Kadowaki N
Sci Rep; 2023 Aug; 13(1):13005. PubMed ID: 37563148
[TBL] [Abstract][Full Text] [Related]
9. Monocyte-predominant engraftment, cytokine levels and early transplant-related complications in pediatric hematopoietic stem cell recipients.
Maximova N; Granzotto M; Barbieri F; Marcuzzi A; Tommasini A; Monasta L; Simeone R; Zanon D; Sala R
Cancer Med; 2019 Mar; 8(3):890-901. PubMed ID: 30690926
[TBL] [Abstract][Full Text] [Related]
10. Kidney Disease Following Hematopoietic Stem Cell Transplantation.
Abudayyeh A; Wanchoo R
Adv Chronic Kidney Dis; 2022 Mar; 29(2):103-115.e1. PubMed ID: 35817518
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Total Body Irradiation-based Versus Chemotherapy-based Conditionings for Early Complications of Allogeneic Hematopoietic Stem Cell Transplantation in Children With ALL.
Yalcin K; Pehlivan B; Celen S; Bas EG; Kabakci C; Pashayev D; Daloglu H; Zhumatayev S; Uygun V; Karasu GT; Hazar V; Yesilipek A
J Pediatr Hematol Oncol; 2021 Oct; 43(7):266-270. PubMed ID: 33625092
[TBL] [Abstract][Full Text] [Related]
12. Incidence, Predictors, and Outcomes of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation.
Lewis C; Kim HT; Roeker LE; Cutler C; Koreth J; Nikiforow S; Armand P; Gootpu M; Romee R; Glotzbecker B; Nageshwar P; Antin JH; Alyea EP; Richardson P; Soiffer RJ; Ho VT
Biol Blood Marrow Transplant; 2020 Mar; 26(3):529-539. PubMed ID: 31678537
[TBL] [Abstract][Full Text] [Related]
13. Systematic Review of Signs and Symptoms Associated with Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy.
Dandoy CE; Tsong WH; Sarikonda K; McGarvey N; Perales MA
Transplant Cell Ther; 2023 Apr; 29(4):282.e1-282.e9. PubMed ID: 36592719
[TBL] [Abstract][Full Text] [Related]
14. Abnormal echocardiography 7 days after stem cell transplantation may be an early indicator of thrombotic microangiopathy.
Dandoy CE; Davies SM; Hirsch R; Chima RS; Paff Z; Cash M; Ryan TD; Lane A; El-Bietar J; Myers KC; Jodele S
Biol Blood Marrow Transplant; 2015 Jan; 21(1):113-8. PubMed ID: 25300868
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of schistocyte monitoring after haematopoietic stem cell transplantation.
Lesesve JF; Alla F; Dugué F; Salignac S; Clément L; Lecompte T; Bordigoni P
Int J Lab Hematol; 2011 Aug; 33(4):343-56. PubMed ID: 21284831
[TBL] [Abstract][Full Text] [Related]
16. Thrombotic microangiopathy with concomitant GI aGVHD after allogeneic hematopoietic stem cell transplantation: Risk factors and outcome.
Zhang XH; Liu X; Wang QM; He Y; Zhu XL; Zhang JM; Han W; Chen H; Chen YH; Wang FR; Wang JZ; Zhang YY; Mo XD; Chen Y; Wang Y; Fu HX; Chang YJ; Xu LP; Liu KY; Huang XJ
Eur J Haematol; 2018 Feb; 100(2):171-181. PubMed ID: 29114931
[TBL] [Abstract][Full Text] [Related]
17. Thrombotic and hemorrhagic complications in children and young adult recipients of Hematopoietic Stem Cell Transplant (HSCT).
Kaur D; Ashrani AA; Pruthi R; Khan SP; Bailey K; Rodriguez V
Thromb Res; 2018 Jul; 167():44-49. PubMed ID: 29787942
[TBL] [Abstract][Full Text] [Related]
18. Liver disease during and after hematopoietic stem cell transplantation in adults: a single-center Egyptian experience.
Abdelbary H; Magdy R; Moussa M; Abdelmoaty I
J Egypt Natl Canc Inst; 2020 Feb; 32(1):11. PubMed ID: 32372257
[TBL] [Abstract][Full Text] [Related]
19. Transjugular Intrahepatic Portosystemic Shunt for Very Severe Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) after Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation with Post-transplantation Cyclophosphamide.
Gómez-Centurión I; Bailén R; Oarbeascoa G; Muñoz C; Luque AÁ; Boyra ME; Calleja E; Rincón D; Dorado N; Barzallo P; Anguita J; Díez-Martín JL; Kwon M
Biol Blood Marrow Transplant; 2020 Nov; 26(11):2089-2097. PubMed ID: 32791193
[TBL] [Abstract][Full Text] [Related]
20. [Clinical outcome of allogeneic hematopoietic stem cell transplantation with FLAG sequential busulfan/cyclophosphamide conditioning regimen for refractory/relapsed acute myeloid leukemia].
Liu W; Li Y; Qiu ZX; Yin Y; Sun YH; Xu WL; Wang Q; Liang ZY; Dong YJ; Wang LH; Cen QN; Wang MJ; Wang WS; Ou JP; Ren HY
Zhonghua Nei Ke Za Zhi; 2018 Aug; 57(8):576-581. PubMed ID: 30060329
[No Abstract] [Full Text] [Related]
[Next] [New Search]
